Ryan Donnelly (pharmaceutical scientist)

Ryan Donnelly is a pharmaceutical scientist primarily known for his research in the field of transdermal drug delivery and microneedle technology. He holds a professorship in pharmaceutical technology, often at a university in the United Kingdom or Ireland, with specific affiliations changing over time.

Donnelly's research focuses on developing novel drug delivery systems to improve therapeutic outcomes. His work encompasses various aspects of transdermal delivery, including:

• Microneedle Technology: Developing and characterizing microneedles for enhanced drug penetration through the skin. This includes exploring different microneedle materials, designs, and fabrication methods.
• Transdermal Patches: Investigating and optimizing transdermal patches for the controlled release of drugs through the skin.
• Drug Formulation and Delivery: Studying the impact of drug properties and formulation on transdermal absorption.
• Biopharmaceutical Considerations: Examining the biopharmaceutical factors affecting drug permeation through the skin.
• In Vitro and In Vivo Studies: Conducting laboratory and animal studies to evaluate the efficacy and safety of transdermal drug delivery systems.
• Translation to Clinical Applications: Working toward the clinical translation of novel drug delivery technologies.

Donnelly has authored and co-authored numerous peer-reviewed publications in leading pharmaceutical journals and presented his research at international conferences. He is often involved in collaborative research projects with academic institutions and pharmaceutical companies. He often holds patents related to his drug delivery technologies. The specific university affiliation and titles held by Donnelly should be checked with up-to-date sources for the most current information.